ersonal use only
Prof. Rob Phillips
Chairman and CEO, Uscom Limited
May 2, 2022
Building the Future
Update
• Transformational Partnership
• New Products
• Expanded Markets
• Operational Agility
• Positioned for Growth
ASX: UCM
Uscom Update
ersonal use only
"While the world has been stunned by destabilised geopolitics, the pandemic and now war, Uscom continues to actively pursue global opportunity, international trade, operational expansion, and growth strategies while strengthening our position as a global advanced medical technology leader. During the last 6 months we have been forming transformational partnerships with global technology leaders, developing new products, appointing new distributors, establishing new regional operations, advancing clinical science, writing new IP, and advancing global trade; we are building the future of global medical technology."
Prof. Rob Phillips
(CEO of Uscom)
Medical Technology
ylno esu lanosre
GLOBAL VALUE
"Medical technology is the application of organized
knowledge and skills in the form of devices, medicines,
vaccines, procedures, and systems developed to solve a
health problem and improve quality of lives."
WHO
"Uscom is a world leading ASX listed, advanced medical technology company specialising in cardiovascular and pulmonary monitoring devices, with a global operational footprint and leadership in medical science and technology. Uscom has a global web of ~200 patents and IP applications, and over 600 publications validating the clinical benefits of its technologies."
Prof. Rob Phillips
Overview
ersonal use only
ASX Listed
Global cardiovascular and pulmonary medical technology
Visionary and innovative
corporate culture
Profit and Cash Flow
Profit & Cash Flow +ve China and Europe, 5 yrs operating cash and debt freeHigh Growth and Margins 9 year: total receipts up 535% and
24% CAGR.
Huge global addressable markets - 75% of all mortality
Margins 75%+
Global Vision and Ambitions
Sydney, Singapore, Beijing, Budapest, Auckland, London, Delawere. Actively focused on growth and scale
Patented Apex Technologies
World leading digital medical technologies, >200 IP submissions and a healthy R&D supported product pipeline
New Products
New global regulatory and distribution 3 new products for 2022
Product approvals for 2022 - up ~140%
Uscom Snapshot
Uscom is an established medical technology enterprise preparing for a growth inflection with a global footprint and an expanding international network of operations acting as hubs for new distributors
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Uscom Limited published this content on 02 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 May 2022 02:46:05 UTC.